Ticker Symbol: STXS
Stereotaxis Inc
$6.84 - 20-11-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001289340
Company Profile
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis' systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3845
Address: 4320 Forest Park Ave Ste 100
Website: www.stereotaxis.com
CEO: David Fischel
Tags:
- Medical Specialties
- Health Technology
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $1.51
Change:
-
(
0.00%)
Days Range: $1.50 - $1.56
Beta: 0.55
52wk. High: $2.75
52wk. Low: $1.33
Ytd. Change -27.05%
50 Day Moving Average: $1.62
200 Day Moving Average: $1.70
Shares Outstanding: 80868280
Valuation
Market Cap: 12.2B
PE Ratio: -5.65
EPS (TTM): -0.2674
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A